Generative Adversarial Networks for Intrusion Detection Systems: A Comprehensive Survey of Applications, Challenges, and Research Directions. [PDF]
Alauthman M +4 more
europepmc +1 more source
Fluid Biomarkers of Disease Burden and Cognitive Dysfunction in Progressive Supranuclear Palsy
ABSTRACT Objective Identifying objective biomarkers for progressive supranuclear palsy (PSP) is crucial to improving diagnosis and establishing clinical trial and treatment endpoints. This study evaluated fluid biomarkers in PSP versus controls and their associations with regional 18F‐PI‐2620 tau‐PET, clinical, and cognitive outcomes.
Roxane Dilcher +10 more
wiley +1 more source
Exploring the Influence of Salinity Intrusion on the Physical and Menstrual Health Problem of Women in Coastal Bangladesh. [PDF]
Yasmin F, Khanam D, Alam MS, Billah M.
europepmc +1 more source
Functional and Structural Evidence of Neurofluid Circuit Aberrations in Huntington Disease
ABSTRACT Objective Disrupted neurofluid regulation may contribute to neurodegeneration in Huntington disease (HD). Because neurofluid pathways influence waste clearance, inflammation, and the distribution of central nervous system (CNS)–delivered therapeutics, understanding their dysfunction is increasingly important as targeted treatments emerge.
Kilian Hett +8 more
wiley +1 more source
Toward Energy-Efficient and Low-Carbon Intrusion Detection in Edge and Cloud Computing Based on GreenShield Cybersecurity Framework. [PDF]
Alshammari A.
europepmc +1 more source
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane +43 more
wiley +1 more source
Clinical Applications of Orthodontic Mini-Implants in Orthodontic and Esthetic Practice: A Case Series Exploring Biomechanical Versatility. [PDF]
Bungău TC, Radu A, Ciavoi G.
europepmc +1 more source
Clinical Validation of Plasma p‐217tau in Neurological Diseases
ABSTRACT Objective Plasma p‐217tau is a minimally invasive but specific biomarker for diagnosing Alzheimer's disease (AD). However, its disease specificity remains to be clinically evaluated. We validated the reliability of the p‐217tau biomarker in 12 other neurological diseases.
Takeshi Kawarabayashi +13 more
wiley +1 more source
A 3D comparison of planned versus achieved anterior tooth position in clear aligner treatment. [PDF]
Saif BS +9 more
europepmc +1 more source
RETRACTION: J. Chen, C. Chen, Y. Lin, Y. Su, X. Yu, Y. Jiang, Z. Chen, SY. Ke, SZ. Lin, L. Chen, Z. Zhang, and T. Zhang, “Downregulation of SUMO2 inhibits hepatocellular carcinoma cell proliferation, migration and invasion,” FEBS Open Bio 11, no. 6 (2021): 1771–1784. https://doi.org/10.1002/2211-5463.13173. The above article, published online on 14 May
wiley +1 more source

